IKK/NF-κB signaling pathway inhibits cell-cycle progression by a novel Rb-independent suppression system for E2F transcription factors

Oncogene

Volumn 27, Issue 43, 2008, Pages 5696-5705

  Araki, K ^a   Kawauchi, K ^a   Tanaka, N ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Cell cycle; E2F; HAT; IKK; NF B; Rb

Indexed keywords

HAT COFACTOR TRANSACTIVATION TRANSFORMATION DOMAIN ASSOCIATED PROTEIN; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; PROTEIN; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR E2F2; TRANSCRIPTION FACTOR E2F3; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG; DNA; HISTONE ACETYLTRANSFERASE; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NUCLEAR PROTEIN; RELA PROTEIN, MOUSE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TRANSFORMATION TRANSCRIPTION DOMAIN ASSOCIATED PROTEIN; TRANSFORMATION-TRANSCRIPTION DOMAIN-ASSOCIATED PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL CYCLE PROGRESSION; CELL GROWTH; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; EMBRYO; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MOUSE; MULTIGENE FAMILY; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; ANIMAL; CELL CYCLE; CELL NUCLEUS; CELL STRAIN 3T3; DRUG ANTAGONISM; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; PROMOTER REGION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CELL CYCLE; CELL NUCLEUS; DNA; E2F TRANSCRIPTION FACTORS; HISTONE ACETYLTRANSFERASES; HUMANS; I-KAPPA B KINASE; MICE; NF-KAPPA B; NIH 3T3 CELLS; NUCLEAR PROTEINS; PHOSPHORYLATION; PROMOTER REGIONS (GENETICS); RETINOBLASTOMA PROTEIN; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 52949090392     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2008.184     Document Type: Article

References (32)

1. Aggarwal BB. (2003). Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol 3: 745-756.
2. Aggarwal BB, Pocsik E, Totpal K, Ali-Osman F. (1995). Suppression of antiproliferative effects of tumor necrosis factor by transfection of cells with human platelet-derived growth factor B/c-sis gene. FEBS Lett 357: 1-6.
3. Ait-Si-Ali S, Polesskaya A, Filleur S, Ferreira R, Duquet A, Robin P et al. (2000). CBP/p300 histone acetyl-transferase activity is important for the G1/S transition. Oncogene 19: 2430-2437.
4. Banno T, Gazel A, Blumenberg M. (2004). Effects of tumor necrosis factor-α (TNFα) in epidermal keratinocytes revealed using global transcriptional profiling. J Biol Chem 279: 32633-32642.
5. Boehm JS, Hession MT, Bulmer SE, Hahn WC. (2005). Transformation of human and murine fibroblasts without viral oncoproteins. Mol Cell Biol 25: 6464-6474.
6. Brantley DM, Chen CL, Muraoka RS, Bushdid PB, Bradberry JL, Kittrell F et al. (2001). Nuclear factor-κB (NF-κB) regulates proliferation and branching in mouse mammary epithelium. Mol Biol Cell 12: 1445-1455.
7. DeGregori J, Johnson DG. (2006). Distinct and overlapping roles for E2F family members in transcription, proliferation and apoptosis. Curr Mol Med 6: 739-748.
8. Delhase M, Hayakawa M, Chen Y, Karin M. (1999). Positive and negative regulation of IκB kinase activity through IKKβ subunit phosphorylation. Science 284: 309-313.
9. Ferreira R, Naguibneva I, Pritchard LL, Ait-Si-Ali S, Harel-Bellan A. (2001). The Rb/chromatin connection and epigenetic control: opinion. Oncogene 20: 3128-3133.
10. Frolov MV, Dyson NJ. (2004). Molecular mechanisms of E2F-dependent activation and pRB-mediated repression. J Cell Sci 117: 2173-2181.
11. Hahn WC, Dessain SK, Brooks MW, King JE, Elenbaas B, Sabatini DM et al. (2002). Enumeration of the simian virus 40 early region elements necessary for human cell transformation. Mol Cell Biol 22: 2111-2123.
12. Huang WC, Ju TK, Hung MC, Chen CC. (2007). Phosphorylation of CBP by IKKα promotes cell growth by switching the binding preference of CBP from p53 to NF-κB. Mol Cell 26: 75-87.
13. Karin M. (2006). Nuclear factor-κB in cancer development and progression. Nature 441: 431-436.
14. Karin M, Ben-Neriah Y. (2000). Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu Rev Immunol 18: 621-663.
15. Lang SE, McMahon SB, Cole MD, Hearing P. (2001). E2F transcriptional activation requires TRRAP and GCN5 cofactors. J Biol Chem 276: 32627-32634.
16. Li Q, Verma IM. (2002). NF-κB regulation in the immune system. Nat Rev Immunol 2: 725-734.
17. Li Q, Withoff S, Verma IM. (2005). Inflammation-associated cancer: NF-κB is the lynchpin. Trends Immunol 26: 318-325.
18. Martinez-Balbas MA, Bauer UM, Nielsen SJ, Brehm A, Kouzarides T. (2000). Regulation of E2F1 activity by acetylation. EMBO J 19: 662-671.
19. Marzio G, Wagener C, Gutierrez MI, Cartwright P, Helin K, Giacca M. (2000). E2F family members are differentially regulated by reversible acetylation. J Biol Chem 275: 10887-10892.
20. McMahon SB, Van Buskirk HA, Dugan KA, Copeland TD, Cole MD. (1998). The novel ATM-related protein TRRAP is an essential cofactor for the c-Myc and E2F oncoproteins. Cell 94: 363-374.
21. Pasparakis M, Courtois G, Hafner M, Schmidt-Supprian M, Nenci A, Toksoy A et al. (2002). TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2. Nature 417: 861-866.
22. Rowland BD, Bernards R. (2006). Re-evaluating cell-cycle regulation by E2Fs. Cell 127: 871-874.
23. Seitz CS, Deng H, Hinata K, Lin Q, Khavari PA. (2000). Nuclear factor κB subunits induce epithelial cell growth arrest. Cancer Res 60: 4085-4092.
24. Seitz CS, Lin Q, Deng H, Khavari PA. (1998). Alterations in NF-κB function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-κB. Proc Natl Acad Sci USA 95: 2307-2312.
25. Spyridopoulos I, Principe N, Krasinski KL, Xu S, Kearney M, Magner M et al (1998). Restoration of E2F expression rescues vascular endothelial cells from tumor necrosis factor-α-induced apoptosis. Circulation 98: 2883-2890.
26. Takahashi Y, Rayman JB, Dynlacht BD. (2000). Analysis of promoter binding by the E2F and pRB families in vivo: distinct E2F proteins mediate activation and repression. Genes Dev 14: 804-816.
27. Taubert S, Gorrini C, Frank SR, Parisi T, Fuchs M, Chan HM et al. (2004). E2F-dependent histone acetylation and recruitment of the Tip60 acetyltransferase complex to chromatin in late G1. Mol Cell Biol 24: 4546-4556.
28. Tergaonkar V, Correa RG, Ikawa M, Verma IM. (2005). Distinct roles of IκB proteins in regulating constitutive NF-κB activity. Nat Cell Biol 7: 921-923.
29. Trimarchi JM, Lees JA. (2002). Sibling rivalry in the E2F family. Nat Rev Mol Cell Biol 3: 11-20.
30. Trouche D, Cook A, Kouzarides T. (1996). The CBP co-activator stimulates E2F1/DP1 activity. Nucleic Acids Res 24: 4139-4145.
31. Tu Z, Prajapati S, Park KJ, Kelly NJ, Yamamoto Y, Gaynor RB. (2006). IKKα regulates estrogen-induced cell cycle progression by modulating E2F1 expression. J Biol Chem 281: 6699-6706.
32. Wang CY, Mayo MW, Baldwin AS. (1996). TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science 274: 784-787.